Cameron Piron

Sentinelle technology is developed by clinicians for clinicians and has evolved over ten years and more than 10000 patient trials. Its products come out of diagnostic imaging research initially conducted at Sunnybrook Health Sciences Centre and the University of Toronto Medical Biophysics department, and continuing over the past three years at Sentinelle. Its ongoing collaboration with academic institutions ensures Sentinelle technology is at the leading edge of the field of breast MRI imaging advances. Sentinelle develops products for General Electric Healthcare, Siemens Medical Solutions and Toshiba Medical Systems. Sentinelle Medical Inc., established in 2004, is a private company based in Toronto, Canada.

Synaptive Medical, Inc. develops medical equipment and applications for neurosurgery. Its products include birghtmatter plan, guide, drive, vision and imagedrive. The firm?s solutions offer state-of-the-art technologies, including advanced surgical planning, navigation and visualization. The company was founded by Cameron Piron in 2012 and is headquartered in Toronto, Canada.

Orthogonal, Inc. is advancing the field of display manufacturing by lifting the constraints of traditional photolithography. The firm solutions include high resolution OLED (VR), organic semiconductor, TV OLED manufacturing and mobile OLED manufacturing. The company was founded by John DeFranco and is headquartered in Rochester, NY.

Conavi Medical, Inc. develops, manufactures, sells, and supports technologies to help guide minimally invasive procedures. It provides imaging devices for use during procedures performed by electrophysiologists and interventional cardiologists. The company was founded by Brian Courtney and Amandeep Thind in 2007 and is headquartered in Toronto, Canada.

Cora Therapeutics, Inc. is a data-driven health solutions company based in Toronto, CA. The product is clinically proven and patented to minimize the irreversible damage to DNA caused by radiation from medical imaging such as CT and X-ray, and cosmic radiation on planes at high altitudes. The Canadian company, under the leadership of Dr. Kieran Murphy, a renowned interventional neuroradiologist, is committed to minimizing the collateral damage caused by radiation exposure. The team is complemented by the esteemed scientific advisor, Dr. Mark Tarnopolsky, who is a frontrunner in evaluating and developing nutraceutical treatments for disorders associated with oxidative stress. The company's first product, Halo antioxidant, is launching in 2022. The company's formulations are developed using the wealth of knowledge possessed by their team and validated through clinical research. The company was founded by Kieran Murphy, and the CEO is David Simpson.